Alison Bauerlein - 14 Jun 2022 Form 4 Insider Report for Pear Therapeutics, Inc.

Role
Director
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 16:12:35 UTC
Previous filing
09 May 2022
Next filing
17 Feb 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PEARQ Restricted Stock Units Award $0 +100,000 $0.000000 100,000 14 Jun 2022 Class A Common Stock 100,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
F2 The restricted stock units shall vest and settle as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a "separation from service" within the meaning of Section 409A of the Internal Revenue Code (the "Separation Date"), provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested).